These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Characterization of cell-bound papain-soluble beta-lactamases in BRO-1 and BRO-2 producing strains of Moraxella (Branhamella) catarrhalis and Moraxella nonliquefaciens. Eliasson I, Kamme C, Vang M, Waley SG. Eur J Clin Microbiol Infect Dis; 1992 Apr; 11(4):313-21. PubMed ID: 1396750 [Abstract] [Full Text] [Related]
5. A membrane-bound precursor beta-lactamase in strains of Moraxella catarrhalis and Moraxella nonliquefaciens that produce periplasmic BRO-1 and BRO-2 beta-lactamases. Steingrube VA, Wallace RJ, Beaulieu D. J Antimicrob Chemother; 1993 Feb; 31(2):237-44. PubMed ID: 8463169 [Abstract] [Full Text] [Related]
6. Antimicrobial susceptibility and beta-lactamase characterization of Branhamella catarrhalis isolates from 1983/1984 and 1988. Christensen JJ, Keiding J, Bruun B. APMIS; 1990 Nov; 98(11):1039-44. PubMed ID: 2123390 [Abstract] [Full Text] [Related]
7. BRO beta-lactamases of Branhamella catarrhalis and Moraxella subgenus Moraxella, including evidence for chromosomal beta-lactamase transfer by conjugation in B. catarrhalis, M. nonliquefaciens, and M. lacunata. Wallace RJ, Steingrube VA, Nash DR, Hollis DG, Flanagan C, Brown BA, Labidi A, Weaver RE. Antimicrob Agents Chemother; 1989 Nov; 33(11):1845-54. PubMed ID: 2514622 [Abstract] [Full Text] [Related]
10. Evaluation of restriction endonuclease analysis of BRO beta-lactamases in clinical and carrier isolates of Moraxella catarrhalis. Köseoglu O, Ergin A, Hascelik G. Scand J Infect Dis; 2004 Apr; 36(6-7):431-4. PubMed ID: 15307563 [Abstract] [Full Text] [Related]
11. beta-Lactam resistance and beta-lactamase isoforms of Moraxella catarrhalis isolates in Taiwan. Fung CP, Lee SC, Liu PY, Jang TN, Wong FD, Kuo BI, Liu CY, Liu YC. J Formos Med Assoc; 1998 Jul; 97(7):453-7. PubMed ID: 9700241 [Abstract] [Full Text] [Related]
12. The frequency of BRO β-lactamase and its relationship to antimicrobial susceptibility and serum resistance in Moraxella catarrhalis. Saito R, Nonaka S, Fujinami Y, Matsuoka S, Nakajima S, Nishiyama H, Okamura N. J Infect Chemother; 2014 Jan; 20(1):6-8. PubMed ID: 24462416 [Abstract] [Full Text] [Related]
13. The beta-lactamases of Moraxella (Branhamella) catarrhalis isolated from Danish children. Ejlertsen T, Skov R. APMIS; 1996 Jan; 104(7-8):557-62. PubMed ID: 8920809 [Abstract] [Full Text] [Related]
14. Antimicrobial susceptibility to β-lactam antibiotics and production of BRO β-lactamase in clinical isolates of Moraxella catarrhalis from a Japanese hospital. Yamada K, Arai K, Saito R. J Microbiol Immunol Infect; 2017 Jun; 50(3):386-389. PubMed ID: 28057435 [Abstract] [Full Text] [Related]
15. Plasmid-mediated beta-lactamase in Branhamella catarrhalis. Kamme C, Eliasson I, Knutson BK, Vang M. Drugs; 1986 Jun; 31 Suppl 3():55-63. PubMed ID: 3488198 [Abstract] [Full Text] [Related]
16. bro {beta}-lactamase and antibiotic resistances in a global cross-sectional study of Moraxella catarrhalis from children and adults. Khan MA, Northwood JB, Levy F, Verhaegh SJ, Farrell DJ, Van Belkum A, Hays JP. J Antimicrob Chemother; 2010 Jan; 65(1):91-7. PubMed ID: 19889789 [Abstract] [Full Text] [Related]